Sutro Biopharma (STRO) Short Interest Ratio & Short Volume → Things Are Not Normal in America – Here’s What to Do (From Stansberry Research) (Ad) Free STRO Stock Alerts $4.36 +0.08 (+1.87%) (As of 12:49 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Sutro Biopharma Short Interest DataCurrent Short Volume2,180,000 sharesPrevious Short Volume2,410,000 sharesChange Vs. Previous Month-9.54%Dollar Volume Sold Short$9.03 millionShort Interest Ratio / Days to Cover2.2Last Record DateApril 15, 2024Outstanding Shares62,440,000 sharesPercentage of Shares Shorted3.49%Today's Trading Volume259,478 sharesAverage Trading Volume950,622 sharesToday's Volume Vs. Average27% Short Selling Sutro Biopharma ? Sign up to receive the latest short interest report for Sutro Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSTRO Short Interest Over TimeSTRO Days to Cover Over TimeSTRO Percentage of Float Shorted Over Time Ad InvestorPlace1970’s computer coder Issues Shocking AI WarningLouis Navellier has spent four decades building a billion-dollar empire on the back of big data and technology… Now he's stepping forward with a shocking warning about how AI will soon impact the wealth of everyday Americans.Click here to watch his new video ASAP Sutro Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,180,000 shares $9.03 million -9.5%N/A2.2 $4.14 3/31/20242,410,000 shares $13.62 million +3.9%N/A2.3 $5.65 3/15/20242,320,000 shares $9.54 million -3.7%N/A2.6 $4.11 2/29/20242,410,000 shares $11.83 million -9.7%N/A2.9 $4.91 2/15/20242,670,000 shares $11.99 million +2.3%N/A3.2 $4.49 1/31/20242,610,000 shares $11.33 million +8.8%N/A2.9 $4.34 Get the Latest News and Ratings for STRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sutro Biopharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/20242,400,000 shares $9.60 million +1.7%N/A2.7 $4.00 12/31/20232,360,000 shares $10.12 million +24.2%N/A2.6 $4.29 12/15/20231,900,000 shares $7.56 million -8.2%N/A2.4 $3.98 11/30/20232,070,000 shares $5.40 million -10.0%N/A3 $2.61 11/15/20232,300,000 shares $5.66 million -3.0%N/A3.7 $2.46 10/31/20232,370,000 shares $6.52 million -4.4%N/A5.3 $2.75 10/15/20232,480,000 shares $9.77 million +5.1%N/A6.2 $3.94 9/30/20232,360,000 shares $8.19 million -2.5%N/A6.3 $3.47 9/15/20232,420,000 shares $9.46 million +28.7%N/A7.9 $3.91 8/31/20231,880,000 shares $8.93 million -2.1%N/A4.5 $4.75 8/15/20231,920,000 shares $8.20 million -1.5%N/A4.5 $4.27 7/31/20231,950,000 shares $8.72 million -1.5%N/A4.3 $4.47 7/15/20231,980,000 shares $9.37 million +2.1%N/A4 $4.73 6/30/20231,940,000 shares $9.02 million -36.8%N/A3.8 $4.65 6/15/20233,070,000 shares $16.61 million +2.0%N/A5.6 $5.41 5/31/20233,010,000 shares $13.51 million -2.9%N/A6.2 $4.49 5/15/20233,100,000 shares $18.23 million +4.4%N/A6.6 $5.88 4/30/20232,970,000 shares $12.65 million -2.3%N/A6.5 $4.26 4/15/20233,040,000 shares $13.38 million +8.6%N/A7.1 $4.40 3/31/20232,800,000 shares $12.94 million +77.2%N/A5.5 $4.62 3/15/20231,580,000 shares $8.53 million -16.0%N/A2.9 $5.40 2/28/20231,880,000 shares $10.60 million +0.5%N/A3.3 $5.64 2/15/20231,870,000 shares $11.61 million -3.6%N/A3.3 $6.21 1/31/20231,940,000 shares $14.05 million -8.1%N/A3.4 $7.24 1/15/20232,110,000 shares $16.61 million +8.2%N/A3.6 $7.87 12/30/20221,950,000 shares $15.76 million -22.9%N/A3.7 $8.08 12/15/20222,530,000 shares $18.60 million -4.2%N/A5.3 $7.35 11/30/20222,640,000 shares $19.77 million -30.7%N/A6.9 $7.49 11/15/20223,810,000 shares $27.93 million -8.2%N/A10.7 $7.33 10/31/20224,150,000 shares $30.42 million +0.2%9.2%12.6 $7.33 10/15/20224,140,000 shares $23.14 million +2.7%9.2%11.3 $5.59 9/30/20224,030,000 shares $22.37 million -5.0%8.9%11.3 $5.55 9/15/20224,240,000 shares $24.34 million -11.3%9.4%5.8 $5.74 8/31/20224,780,000 shares $27.05 million -7.9%10.8%5.8 $5.66Exposed: 10 CENT Crypto to Explode May 20th? (Ad)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 STRO Short Interest - Frequently Asked Questions What is Sutro Biopharma's current short interest? Short interest is the volume of Sutro Biopharma shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 2,180,000 shares of STRO short. Learn More on Sutro Biopharma's current short interest. What is a good short interest ratio for Sutro Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. STRO shares currently have a short interest ratio of 2.0. Learn More on Sutro Biopharma's short interest ratio. Is Sutro Biopharma's short interest increasing or decreasing? Sutro Biopharma saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 2,180,000 shares, a decline of 9.5% from the previous total of 2,410,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Sutro Biopharma's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Sutro Biopharma: Adaptimmune Therapeutics plc (1.38%), Fennec Pharmaceuticals Inc (8.08%), Coherus BioSciences, Inc. (18.97%), Candel Therapeutics, Inc. (12.96%), Poseida Therapeutics, Inc. (6.55%), Monte Rosa Therapeutics, Inc. (5.91%), Agenus Inc. (13.01%), Invivyd, Inc. (7.05%), Compass Therapeutics, Inc. (1.88%), Century Therapeutics, Inc. (6.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Sutro Biopharma stock? Short selling STRO is an investing strategy that aims to generate trading profit from Sutro Biopharma as its price is falling. STRO shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sutro Biopharma? A short squeeze for Sutro Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of STRO, which in turn drives the price of the stock up even further. How often is Sutro Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including STRO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ADAP Short Squeeze FENC Short Squeeze CHRS Short Squeeze CADL Short Squeeze PSTX Short Squeeze GLUE Short Squeeze AGEN Short Squeeze IVVD Short Squeeze CMPX Short Squeeze IPSC Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:STRO) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold Group